Navamedic ASA - Investor presentation regarding the acquisition of the business of dne pharma AS

For further information, please contact: For further information, please contact: Kathrine Gamborg Andreassen, CEO, Mobile: +47 951 78 880 E-mail:[email protected] Hjarrand, CFO, Mobile: +47 917 62 842 E-mail:[email protected] About Navamedic Navamedic ASA is a full-service provider of high-quality healthcare products to hospitals and pharmacies. Navamedic meets the specific medical needs of patients and consumers by leveraging its highly scalable market...
Comunicato Precedente

next
Comunicato Successivo

next

For further information, please contact:

Kathrine Gamborg Andreassen, CEO, Mobile: +47 951 78 880 E-mail: [email protected]
Lars Hjarrand, CFO, Mobile: +47 917 62 842 E-mail: [email protected]

About Navamedic

Navamedic ASA is a full-service provider of high-quality healthcare products to hospitals and pharmacies. Navamedic meets the specific medical needs of patients and consumers by leveraging its highly scalable market access platform, leading category competence and local knowledge. Navamedic is present in all the Nordic countries, the Baltics and Benelux, with sales representation in Greece. Navamedic is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (OSE: NAVA). For more information, please visit www.navamedic.com.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/navamedic-asa/r/navamedic-asa---investor-presentation-regarding-the-acquisition-of-the-business-of-dne-pharma-as,c4167735

The following files are available for download:

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/navamedic-asa--investor-presentation-regarding-the-acquisition-of-the-business-of-dne-pharma-as-302489311.html

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;